PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Of 50,000 small molecules tested to fight cancer, 2 show promise

2010-11-02
(Press-News.org) BOSTON (3:00 p.m. ET, November 1, 2010) — A class of compounds that interferes with cell signaling pathways may provide a new approach to cancer treatment, according to a study published online this week in the Proceedings of the National Academy of Sciences (PNAS) Early Edition. The compounds, called PITs (non-phosphoinositide PIP3 inhibitors), limited tumor growth in mice by inducing cell death.

"PITs cause cells to self-destruct by interfering with the signaling pathways that regulate cell survival. As compounds that promote cell death, PITs show promise in halting the harmful, unwanted growth characteristic of cancer," said senior author Alexei Degterev, PhD, assistant professor in the biochemistry department at Tufts University School of Medicine (TUSM) and member of the biochemistry program faculty at the Sackler School of Graduate Biomedical Sciences at Tufts.

Degterev teamed up with colleagues at TUSM, Northeastern University, Massachusetts General Hospital, Harvard Medical School, and the National Chemical Laboratory in Pune, India, to identify compounds that could disrupt a cell signaling molecule called PIP3. Out of 50,000 small molecules screened, the team identified two that inhibited PIP3.

"We tested the more stable of these two molecules in mice and found that it inhibited tumor growth and induced cancer cell death," said co-first author Benchun Miao, PhD, formerly a postdoctoral associate in the biochemistry department at TUSM and fellow in Degterev's lab and now a postdoctoral associate in the Nutrition and Cancer Laboratory at the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University.

"We also found that PITs showed an even stronger anti-tumor effect in cells with high PIP3 levels. In humans, these high-PIP3 cells are responsible for aggressive forms of cancer such as glioblastoma," said co-first author Igor Skidan, PhD, formerly a postdoctoral fellow in the department of pharmaceutical sciences at Northeastern University and now a senior scientist at Morphotek, Inc.

According to Degterev, PITs are a promising and relatively unexplored approach to cancer treatment. He says that PITs are a new class of compounds that inhibit PIP3, positioned at an early point in a cell signaling pathway over-activated in many human tumors. The study also presents a methodology for identifying other molecules similar to PITs. Degterev hopes that this approach will help researchers isolate other new compounds that halt cancer growth.

"We are not yet at the stage of considering PITS as leads for therapeutics. Our next focus, with our collaborators at National Chemical Laboratory, will be to develop PITS to be more effective," says Degterev.

### This study was supported by the Smith Family Awards for Excellence in Biomedical Research, a National Institute on Aging Mentored Research Scientist Career Development Award, a US Army Innovator Award; as well as the National Cancer Institute and the National Institute on Aging, both parts of the National Institutes of Health. Patent applications related to the discoveries described in this paper have been filed by Tufts University, Harvard University, and the National Chemical Laboratory, India.

Miao B, Skidan I, Yang J, Lugovskoy A, Reibarkh M, Long K, Brazell T,Durugkar KA, Maki J, Ramana CV, Schaffhausen B, Wagner G, Torchilin V, Yuan J, Degterev A. PNAS Early Edition (November 1, 2010). "Small molecule inhibition of phosphatidylinositol-3,4,5-triphosphate (PIP3) binding to pleckstrin homology domains." Published online November 1, 2010, doi: 10.1073/pnas.1004522107

About Tufts University School of Medicine and the Sackler School of Graduate Biomedical Sciences

Tufts University School of Medicine and the Sackler School of Graduate Biomedical Sciences at Tufts University are international leaders in innovative medical education and advanced research. The School of Medicine and the Sackler School are renowned for excellence in education in general medicine, biomedical sciences, special combined degree programs in business, health management, public health, bioengineering and international relations, as well as basic and clinical research at the cellular and molecular level. Ranked among the top in the nation, the School of Medicine is affiliated with six major teaching hospitals and more than 30 health care facilities. Tufts University School of Medicine and the Sackler School undertake research that is consistently rated among the highest in the nation for its effect on the advancement of medical science.

If you are a member of the media interested in learning more about this topic, or speaking with a faculty member at the Tufts University School of Medicine, the Sackler School of Graduate Biomedical Sciences, or another Tufts health sciences researcher, please contact Siobhan Gallagher at 617-636-6586.

END



ELSE PRESS RELEASES FROM THIS DATE:

Anger makes people want things more

2010-11-02
Anger is an interesting emotion for psychologists. On the one hand, it's negative, but then it also has some of the features of positive emotions. For a new study published in Psychological Science, a journal of the Association for Psychological Science, researchers find that associating an object with anger actually makes people want the object—a kind of motivation that's normally associated with positive emotions. People usually think of anger as a negative emotion. You're not supposed to get angry. But anger also has some positive features. For example, it activates ...

New way of removing excess nitrogen from the environment

2010-11-02
Excess nitrogen from agricultural and urban lands is contaminating groundwater, streams, lakes and estuaries, where it causes harmful algal blooms and contributes to fish kills. Cost-effective approaches to removing this nitrogen from croplands and urban stormwater runoff before it reaches sensitive water bodies have been elusive. But simple and inexpensive technologies are on the horizon. A recent scientific workshop on denitrification brought together ecologists, engineers and policy experts to find answers. Denitrification is a biological process carried out by ...

NYU Courant researchers develop algebraic model to monitor cellular change

2010-11-02
Researchers at New York University's Courant Institute of Mathematical Sciences have developed a novel algebraic model of DNA "hybridization," a process central to most biotechnology devices that monitor changes in cell's gene expression or characterize a cell's genome. Their work, which is described in the journal Physical Review E, provides an additional tool for understanding how biological systems function and could enhance methods and designs of technologies used in cancer and genetics research. Biology researchers seek to measure cell activity, but the task is a ...

Lead poisoning maps in R.I. reveal huge disparities, guide cleanup

2010-11-02
PROVIDENCE, R.I. [Brown University] — The rate at which lead poisoning has struck young Rhode Island children depends heavily on where they live, according to a Brown University-led geographic analysis of comprehensive health department data from across Rhode Island between 1993 and 2005. By mapping cases of lead poisoning, researchers have been able to help target cleanup resources to do the most good. During that 12-year period, some census blocks in the state had no cases of poisoning in the study group of 204,746 children, but in the hardest hit census blocks of Providence, ...

Imaging in depth: 3-dimensional microscopy featured in Cold Spring Harbor Protocols

2010-11-02
COLD SPRING HARBOR, N.Y. (Mon., Nov. 1, 2010) -- Imaging has rapidly become a defining tool of the current era in biological research. But finding the right method and optimizing it for data collection can be a daunting process, even for an established imaging laboratory. Cold Spring Harbor Protocols is one of the world's leading sources for detailed technical instruction for implementation of imaging methods (http://cshprotocols.cshlp.org/cgi/collection/imaging_microscopy_general), and the November issue (http://cshprotocols.cshlp.org/TOCs/toc11_10.dtl) features articles ...

Pitt study finds NSAIDs cause stem cells to self-destruct, preventing colon cancer

2010-11-02
PITTSBURGH, Nov. 1 – Nonsteroidal anti-inflammatory drugs (NSAIDs) prevent colon cancer by triggering diseased stem cells to self-destruct, according to researchers at the University of Pittsburgh Cancer Institute (UPCI) and the University of Pittsburgh School of Medicine. Their findings, reported in the early online version of this week's Proceedings of the National Academy of Sciences, could lead to new strategies to protect people at high risk for the disease. Doctors have long known that NSAIDs, such as aspirin, can lower the risk of colon cancer, but it's not been ...

Rutgers, Chilean astrophysicists discover new galaxy clusters revealed by cosmic 'shadows'

Rutgers, Chilean astrophysicists discover new galaxy clusters revealed by cosmic shadows
2010-11-02
NEW BRUNSWICK, N.J. – An international team of scientists led by Rutgers University astrophysicists have discovered 10 new massive galaxy clusters from a large, uniform survey of the southern sky. The survey was conducted using a breakthrough technique that detects "shadows" of galaxy clusters on the cosmic microwave background radiation, a relic of the "big bang" that gave birth to the universe. In a paper published in the Nov. 10 issue of Astrophysical Journal, the Rutgers scientists and collaborators at the Pontifical Catholic University of Chile (PUC) describe their ...

Microfluidics-imaging platform detects cancer growth signaling in minute biopsy samples

2010-11-02
Inappropriate growth and survival signaling, which leads to the aberrant growth of cancer cells, is a driving force behind tumors. Much of current cancer research focuses on the kinase enzymes whose mutations are responsible for such disregulated signaling, and many successful molecularly targeted anti-cancer therapeutics are directed at inhibiting kinase activity. Now, UCLA researchers from the Crump Institute for Molecular Imaging, the Institute for Molecular Medicine, the California NanoSystems Institute, the Jonsson Comprehensive Cancer Center and the department ...

UV light nearly doubles vacuum's effectiveness in reducing carpet microbes

2010-11-02
COLUMBUS, Ohio – New research suggests that the addition of ultraviolet light to the brushing and suction of a vacuum cleaner can almost double the removal of potentially infectious microorganisms from a carpet's surface when compared to vacuuming alone. Researchers say the findings suggest that incorporating the germicidal properties of UV light into vacuuming might have promise in reducing allergens and pathogens from carpets, as well. "What this tells us is there is a commercial vacuum with UV technology that's effective at reducing surface microbes. This has promise ...

Cancer drug linked to quantum dots increases drug uptake, reduces inflammation

Cancer drug linked to quantum dots increases drug uptake, reduces inflammation
2010-11-02
BUFFALO, N.Y. -- Researchers at the University at Buffalo have developed a novel technology using quantum dots that is expected to have major implications for research and treatment of tuberculosis, as well as other inflammatory lung diseases. A paper appearing online in Nanomedicine: Nanotechnology, Biology and Medicine as an article-in-press describes specific delivery of a chemotherapeutic drug to specific cells in the lung, particularly the alveolar white cell, without causing acute inflammation. Quantum dots are tiny semiconductor particles generally no larger ...

LAST 30 PRESS RELEASES:

Antidepressant shows promise for treating brain tumors

European Green Deal: a double-edged sword for global emissions

Walking in lockstep

New blood test could be an early warning for child diabetes

Oceanic life found to be thriving thanks to Saharan dust blown from thousands of kilometers away

Analysis sheds light on COVID-19-associated disease in Japan

Cooler heads prevail: New research reveals best way to prevent dogs from overheating

UC Riverside medical school develops new curriculum to address substance use crisis

Food fussiness a largely genetic trait from toddlerhood to adolescence

Celebrating a century of scholarship: Isis examines the HSS at 100

Key biomarkers identified for predicting disability progression in multiple sclerosis

Study: AI could lead to inconsistent outcomes in home surveillance

Study: Networks of Beliefs theory integrates internal & external dynamics

Vegans’ intake of protein and essential amino acids is adequate but ultra-processed products are also needed

Major $21 million Australian philanthropic investment to bring future science into disease diagnosis

Innovating alloy production: A single step from ores to sustainable metals

New combination treatment brings hope to patients with advanced bladder cancer

Grants for $3.5M from TARCC fund new Alzheimer’s disease research at UTHealth Houston

UTIA researchers win grant for automation technology for nursery industry

Can captive tigers be part of the effort to save wild populations?

The Ocean Corporation collaborates with UTHealth Houston on Space Medicine Fellowship program

Mysteries of the bizarre ‘pseudogap’ in quantum physics finally untangled

Study: Proteins in tooth enamel offer window into human wellness

New cancer cachexia treatment boosts weight gain and patient activity

Rensselaer researcher receives $3 million grant to explore gut health

Elam named as a Fellow of the Electrochemical Society

Study reveals gaps in access to long-term contraceptive supplies

Shining a light on the roots of plant “intelligence”

Scientists identify a unique combination of bacterial strains that could treat antibiotic-resistant gut infections

Pushing kidney-stone fragments reduces stones’ recurrence

[Press-News.org] Of 50,000 small molecules tested to fight cancer, 2 show promise